• 1
    Ungar WJ, Coyte PC. Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol. 2001; 32:1018.
  • 2
    Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992; 326:8626.
  • 3
    Hall IP. Pharmacogenetics of asthma. Eur Respir J. 2000; 15:44951.
  • 4
    Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg Med J. 2007; 24:82330.
  • 5
    Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005; 90:747.
  • 6
    British Thoracic Society. British Guideline on the Management of Asthma. British Thoracic Society/Scottish Guidelines Intercollegiate Network. Available at: Accessed Aug 10, 2010.
  • 7
    Canadian Asthma Consensus Group. Management of patients with asthma in the emergency department and in hospital. Can Med Assoc J. 1999; 161(11 Suppl):S5359.
  • 8
    Cincinnati Children’s Hospital Medical Center. Evidence Based Clinical Practice Guideline for Managing an Acute Exacerbation of Asthma. Available at: Accessed Nov 11, 2009.
  • 9
    Rowe BH, Camargo CA Jr. Multicenter Airway Research Collaboration I. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol. 2006; 117:538.
  • 10
    Martindale W. Magnesium Sulphate: Adverse Effects. London, UK: The Pharmaceutical Press, 1989, p 1033.
  • 11
    Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med. 2000; 154:97983.
  • 12
    Dillman DA. Mail and Internet Surveys: The Tailored Design Method. New York, NY: Wiley, 1999.
  • 13
    Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd ed. Oxford, UK: Oxford University Press, 1998.
  • 14
    Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA. 1987; 257:10768.
  • 15
    Hughes R, Goldkorn A, Masoli M, Weatherall M, Burgess C, Beasley R. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet. 2003; 361:21147.
  • 16
    Mahajan P, Haritos D, Rosenberg N, Thomas R. Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med. 2004; 27:215.
  • 17
    Paediatric Society of New Zealand. Management of Asthma in Children Aged 1–15 Years. Available at: Accessed Aug 10, 2010.
  • 18
    Couper MP. Web survey design and administration. Pub Opin Q. 2001; 65:23053.
  • 19
    Desu MM, Raghavarao D. Sample Size Methodology. New York, NY: Academic Press, 1990.
  • 20
    Hahn GJ, Meeker WQ. Statistical Intervals. New York, NY: John Wiley & Sons, 1991.
  • 21
    Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods, 3rd ed. Pacific Grove, CA: Duxbury Press, 1998.
  • 22
    Osmond MH, Gazarian M, Henry RL, Clifford TJ, Tetzlaff J. Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey. Acad Emerg Med. 2007; 14:110613.
  • 23
    Tien I, Dorfman D, Kastner B, Bauchner H. Metered-dose inhaler: the emergency department orphan. Arch Pediatr Adolesc Med. 2001; 155:13359.
  • 24
    Knapp JF, Simon SD, Sharma V. Quality of care for common pediatric respiratory illnesses in United States emergency departments: analysis of 2005 National Hospital Ambulatory Medical Care Survey Data. Pediatrics. 2008; 122:116570.
  • 25
    Segal AO, Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics. 2005; 116:515.
  • 26
    Johnson DW, Craig W, Brant R, Mitton C, Svenson L, Klassen TP. A cluster randomized controlled trial comparing three methods of disseminating practice guidelines for children with croup [ISRCTN73394937]. Implement Sci. 2006; 1:e10.
  • 27
    Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001; 39(8 Suppl 2):II4654.
  • 28
    Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998; 76:51763.
  • 29
    Weinberger M. Seventeen years of asthma guidelines: why hasn’t the outcome improved for children? J Pediatr. 2009; 154:7868.
  • 30
    Akinbami L. The state of childhood asthma, United States, 1980–2005. Adv Data. 2006; 381:124.
  • 31
    Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282: 145865.
  • 32
    Cotterell EM, Gazarian M, Henry RL, O’Meara MW, Wales SR. Child and parent satisfaction with the use of spacer devices in acute asthma. J Paediatr Child Health. 2002; 38:6047.
  • 33
    Gazarian M, Henry RL, Wales SR, et al. Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma. Med J Aust. 2001; 174:3947.
  • 34
    Powell CV, Maskell GR, Marks MK, South M, Robertson CF. Successful implementation of spacer treatment guideline for acute asthma. Arch Dis Child. 2001; 84:1426.
  • 35
    Powell C. How to implement change in clinical practice. Paediatr Respir Rev. 2003; 4:3406.
  • 36
    Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr. 1996; 129:80914.
  • 37
    Gurkan F, Haspolat K, Bosnak M, Dikici B, Derman O, Ece A. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. Eur J Emerg Med. 1999; 6:2015.
  • 38
    Devi PR, Kumar L, Singhi SC, Prasad R, Singh M. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatrics. 1997; 34:38997.
  • 39
    Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med. 2000; 36:5728.
  • 40
    Lang ES, Wyer PC, Haynes RB. Knowledge translation: closing the evidence-to-practice gap. Ann Emerg Med. 2007; 49:35563.
  • 41
    Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity. J Pediatr. 2000; 137:7628.
  • 42
    Bloch H, Silverman R, Mancherje N, Grant S, Jagminas L, Scharf SM. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest. 1995; 107:157681.
  • 43
    Asch D, Jedrziewski K, Christakis N. Response rates to surveys published in medical journals. J Clin Epidemiol. 1997; 10:122936.
  • 44
    Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res. 2001; 35:134755.